trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['solid tumor', 'pantumor', 'daiichi']
#latebreaker alert! new data from our destiny-pantumor02 trial in multiple advanced solid tumors was presented at . read more here: #asco23 
We create life-changing solutions for patients. See our guidelines: https://t.co/4iEAbpw1Wx